MedTrace Logo

Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity

NCT02705716 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 409

Last updated 2017-04-25

Study results available
· View outcomes & findings →

Summary

This study will investigate the efficacy of an experimental dentifrice containing 0.454% weight/weight (w/w) stannous fluoride in relieving dentine hypersensitivity (DH) after twice daily brushing, over a 2 week treatment period compared with a standard fluoride dentifrice.

Conditions

  • Dentin Sensitivity

Interventions

OTHER

0.454% w/w stannous fluoride (1100ppm fluoride)

Dentifrice containing 0.454% w/w stannous fluoride (1100ppm fluoride)

OTHER

0.76% sodium monofluorophosphate (1000ppm fluoride)

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2016-05-20
Completion
2016-05-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705716 on ClinicalTrials.gov